Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis

New England Journal of Medicine

Volumn 346, Issue 23, 2002, Pages 1786-1791

  Lachmann, Helen J ^a   Booth, David R ^a   Booth, Susanne E ^a   Bybee, Alison ^a   Gilbertson, Janet A ^a   Gillmore, Julian D ^a   Pepys, Mark B ^a   Hawkins, Philip N ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; FIBRINOGEN; LYSOZYME; PREALBUMIN;

ADULT; AGED; AMYLOIDOSIS; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CLINICAL EXAMINATION; CONTROLLED STUDY; DIAGNOSTIC ERROR; FAMILY HISTORY; GENE MUTATION; HUMAN; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MONOCLONAL IMMUNOGLOBULINEMIA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

ADULT; AGED; AMYLOIDOSIS; AMYLOIDOSIS, FAMILIAL; APOLIPOPROTEIN A-I; DIAGNOSTIC ERRORS; DNA MUTATIONAL ANALYSIS; FEMALE; FIBRINOGEN; GENOTYPE; HETEROZYGOTE; HUMANS; KIDNEY; MIDDLE AGED; MURAMIDASE; PARAPROTEINEMIAS; POINT MUTATION; PREALBUMIN;

EID: 0037030659     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMoa013354     Document Type: Article

References (31)

1. The United Kingdom Medical Research Council's glomerulonephritis registry
2. Allogeneic bone marrow transplantation for systemic AL amyloidosis
3. A trial of three regimens for primary amyloidosis: Colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine
4. The treatment of nephrotic syndrome caused by primary (light chain) amyloid with vincristine, doxorubicin and dexamethasone
5. Myeloablative chemotherapy with stem cell rescue for the treatment of primary systemic amyloidosis: A status report
6. 123I-labeled serum amyloid P component
7. Studies with radiolabelled serum amyloid P component provide evidence for turnover and regression of amyloid deposits in vivo
8. Amyloidosis
9. Transthyretin amyloidosis
10. Variant apolipo protein AI as a major constituent of a human hereditary amyloid
11. Apolipoprotein AI mutation Arg-60 causes autosomal dominant amyloidosis
12. Human lysozyme gene mutations cause hereditary systemic amyloidosis
13. Hereditary renal amyloidosis associated with a mutant fibrinogen α-chain
14. Geographical distribution of TTR met30 carriers in northern Sweden: Discrepancy between carrier frequency and prevalence rate
15. Primary systemic amyloidosis: Clinical and laboratory features in 474 cases
16. Thr-Lys, associated with autosomal dominant cardiac amyloidosis in an Italian family
17. Curative hepatorenal transplantation in systemic amyloidosis caused by the Glu526Val fibrinogen α-chain variant in an English family
18. On the binding of Congo red by amyloid
19. Isolation and characterization of amyloid fibrils from tissue
20. A long-term study of prognosis in monoclonal gammopathy of undetermined significance
21. High-sensitivity diagnosis of AA amyloidosis using Congo red and immunohistochemistry detects missed amyloid deposits
22. Tabulation of (TTR) variants as of 1/1/2000
23. Variant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in black Americans
24. A new human hereditary amyloidosis: The result of a stop-codon mutation in the apolipoprotein AII gene
25. Hereditary renal amyloidosis with a novel variant fibrinogen
26. The molecular basis of renal amyloidosis in Irish-American and Polish-Canadian kindreds
27. Hereditary renal amyloidosis associated with variant lysozyme in a large English family
28. Familial nephropathic systemic amyloidosis caused by apolipoprotein vaoiant Arg26
29. Hereditary amyloid cardiomyopathy caused by a variant apolipoprotein AI
30. Apolipoprotein AI and transthyretin as components of amyloid fibrils in a with apoAI Leul78 His amyloidosis
31. Clinical improvement and amyloid regression after liver transplantation in hereditary, transthyretin amyloidosis